Total Payments
$106,907
2024 Payments
$10,578
Companies
57
Transactions
1,017
Medicare Patients
1,687
Medicare Billing
$359,546
Payment Breakdown by Category
Other$51,180 (47.9%)
Consulting$29,836 (27.9%)
Food & Beverage$23,820 (22.3%)
Education$1,602 (1.5%)
Travel$468.60 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51,180 | 28 | 47.9% |
| Consulting Fee | $29,836 | 10 | 27.9% |
| Food and Beverage | $23,820 | 945 | 22.3% |
| Education | $1,602 | 28 | 1.5% |
| Travel and Lodging | $468.60 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $45,852 | 103 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25,802 | 55 | $0 (2024) |
| Eisai Inc. | $11,040 | 45 | $0 (2024) |
| ARRAY BIOPHARMA INC | $2,731 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,320 | 90 | $0 (2024) |
| Exelixis Inc. | $2,195 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,770 | 82 | $0 (2024) |
| Amgen Inc. | $1,751 | 49 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,339 | 65 | $0 (2024) |
| PFIZER INC. | $1,250 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,578 | 178 | AstraZeneca Pharmaceuticals LP ($6,524) |
| 2023 | $17,918 | 228 | AstraZeneca Pharmaceuticals LP ($13,145) |
| 2022 | $13,801 | 175 | AstraZeneca Pharmaceuticals LP ($6,439) |
| 2021 | $16,843 | 173 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,848) |
| 2020 | $32,074 | 123 | AstraZeneca Pharmaceuticals LP ($16,463) |
| 2019 | $11,654 | 123 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,990) |
| 2018 | $4,038 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,773) |
All Payment Transactions
1,017 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $21.37 | General |
| 12/12/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $118.59 | General |
| Category: Oncology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: Oncology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $0.67 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Oncology | ||||||
| 12/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.34 | General |
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.89 | General |
| 11/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Oncology | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Oncology | ||||||
| 11/12/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $23.34 | General |
| 11/08/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Oncology | ||||||
| 11/07/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OS | ||||||
| 11/07/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.01 | General |
| Category: Hematology/Oncology | ||||||
| 11/02/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Oncology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 337 | 1,651 | $156,987 | $78,880 |
| 2022 | 11 | 389 | 1,901 | $234,766 | $98,002 |
| 2021 | 14 | 515 | 2,242 | $239,747 | $103,673 |
| 2020 | 13 | 446 | 1,459 | $202,575 | $78,992 |
Total Patients
1,687
Total Services
7,253
Medicare Billing
$359,546
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 162 | $37,550 | $20,202 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 178 | $37,885 | $20,123 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 234 | $35,270 | $18,770 | 53.2% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 11 | 81 | $11,160 | $4,994 | 44.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 14 | 140 | $9,154 | $3,789 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $6,029 | $2,991 | 49.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 50 | 280 | $4,540 | $2,131 | 46.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 22 | 22 | $2,961 | $1,612 | 54.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 13 | 110 | $6,040 | $1,604 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 191 | $3,131 | $1,604 | 51.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 73 | $2,920 | $920.55 | 31.5% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 17 | 116 | $298.07 | $117.81 | 39.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 14 | 42 | $48.26 | $21.50 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 280 | $76,983 | $33,050 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 314 | $62,139 | $25,342 | 40.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 16 | 152 | $43,700 | $20,672 | 47.3% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 14 | 226 | $16,130 | $6,755 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $7,873 | $3,704 | 47.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 34 | 35 | $5,160 | $2,742 | 53.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 192 | $7,900 | $2,570 | 32.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 54 | 313 | $8,053 | $2,403 | 29.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 60 | 213 | $6,130 | $630.87 | 10.3% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2022 | 13 | 105 | $525.00 | $111.34 | 21.2% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 16 | 45 | $173.49 | $23.20 | 13.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 268 | $75,060 | $32,634 | 43.5% |
About Dr. Songchuan Guo, M.D
Dr. Songchuan Guo, M.D is a Hematology & Oncology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2011. The National Provider Identifier (NPI) number assigned to this provider is 1013214535.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Songchuan Guo, M.D has received a total of $106,907 in payments from pharmaceutical and medical device companies, with $10,578 received in 2024. These payments were reported across 1,017 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($51,180).
As a Medicare-enrolled provider, Guo has provided services to 1,687 Medicare beneficiaries, totaling 7,253 services with total Medicare billing of $359,546. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Brooklyn, NY
- Active Since 02/18/2011
- Last Updated 09/25/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013214535
Products in Payments
- TAGRISSO (Drug) $44,530
- GILOTRIF (Drug) $22,297
- Lenvima (Drug) $11,040
- BRAFTOVI (Drug) $2,704
- CABOMETYX (Drug) $1,841
- OPDIVO (Biological) $1,492
- KEYTRUDA (Biological) $1,300
- KISQALI (Drug) $673.07
- Pomalyst (Drug) $522.61
- INLYTA (Drug) $437.93
- Stivarga (Drug) $411.77
- BRUKINSA (Drug) $406.01
- DARZALEX (Biological) $398.59
- IBRANCE (Drug) $359.01
- IMFINZI (Biological) $344.43
- MEKINIST (Drug) $341.35
- LIBTAYO (Biological) $332.25
- MONJUVI (Drug) $307.32
- KRAZATI (Drug) $303.00
- JAKAFI (Drug) $297.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brooklyn
Perry Cook, M.d, M.D
Hematology & Oncology — Payments: $1.4M
Hematology & Oncology $1.4M
Yiwu Huang, Md, MD
Hematology & Oncology — Payments: $268,275
Hematology & Oncology $268,275
Dr. Ilya Blokh, M.d, M.D
Hematology & Oncology — Payments: $191,276
Hematology & Oncology $191,276
Yiqing Xu, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $51,145
Hematology & Oncology $51,145
Dr. Azriel Hirschfeld, M.d, M.D
Hematology & Oncology — Payments: $48,699
Hematology & Oncology $48,699
Yan Pronin, P.a, P.A
Hematology & Oncology — Payments: $47,040
Hematology & Oncology $47,040